Resource Center
Guidelines
-
Triglycerides and cardiovascular disease: a scientific statement from the american heart association.
Miller M, Stone NJ, Ballantyne C, et al. Circulation. 2011;123:2292-2333. [Epub 2011.]
-
Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation
Kaul S, Bolger AF, Herrington D, Giugliano RP, Eckel RH. Circulation. 2010;121:1868-1877.
-
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA "Boxed Warning". A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association
Holmes DR Jr, Dehmer GJ, Kaul S, Leifer D, O'Gara PT, Stein CM. Circulation. 2010 Jun 28. [Epub ahead of print].
-
ATP III At-A-Glance: Quick Desk Reference
-
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. September 2002
